Table 1.
Patient information and clinical data: the rheumatoid factor (U/ml) and CCP (U/ml) titre and HLA-DRB1 status of the different RA patients and healthy volunteers used throughout the study
| Patient n° | Gender | Age | RF (U/ml) | CCP (U/ml) | HLA DRB1 |
|---|---|---|---|---|---|
| Healthy controls | |||||
| 1 | F | 22 | ND | ND | 01/08 |
| 2 | F | 45 | <7.9 | 0.3 | 01/04 |
| 3 | F | 32 | <7.9 | 0.4 | 04/13 |
| 4 | M | 37 | <7.9 | 0.4 | 13/15 |
| 5 | M | 32 | <7.9 | 0.4 | 01/07 |
| 6 | F | 45 | <7.9 | 1.4 | 04/11 |
| 7 | F | 45 | <10.6 | 0.4 | 11/11 |
| 8 | F | 24 | ND | ND | 07/14 |
| 9 | F | 28 | ND | ND | 03/09 |
| 10 | M | 26 | ND | ND | ND |
| 11 | M | 63 | <10.6 | 1.1 | 11/13 |
| 12 | F | 26 | ND | ND | ND |
| 13 | F | 30 | ND | ND | ND |
| 14 | F | 61 | <10.6 | 1 | 04/15 |
| 15 | F | 62 | <10.6 | 1.6 | 07/15 |
| 16 | M | 60 | <10.6 | 0.6 | 01/04 |
| 17 | M | 61 | <10.6 | 1.6 | 11/15 |
| 18 | F | 60 | <10.6 | 0.2 | 13/15 |
| 19 | F | 83 | <10.6 | 1.2 | 01/13 |
| RA CCP+ | |||||
| 1 | F | 68 | 105 | 75 | 04/15 |
| 2 | M | 63 | 13.3 | 55 | 01/16 |
| 3 | M | 67 | 100 | 199 | 03/15 |
| 4 | F | 63 | 66.8 | 83 | 01/04 |
| 5 | F | 72 | 30.8 | 75 | 04/04 |
| 6 | F | 81 | <10.6 | >Max | 01/03 |
| 7 | F | 65 | 156 | 611 | 04/04 |
| RA CCP− | |||||
| 1 | M | 67 | <7.9 | 0.4 | 03/07 |
| 2 | M | 73 | <7.9 | 0.6 | 01/15 |
| 3 | M | 67 | <7.9 | 0.5 | 01/07 |
| 4 | F | 68 | <7.9 | 1.1 | 04/04 |
| 5 | M | 62 | <7.9 | 0.5 | 13/16 |
| 6 | F | 46 | <7.9 | 0 | 07/11 |
| 7 | F | 60 | 40.4 | 0.2 | ND |
ND not determined